Apogee Therapeutics Inc (APGE)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-01-10 | 2025-01-08 | PS Planned sale |
Chief Executive Officer Executive Director |
2,868
-0.2%
49.38USD 141,622 |
2,868 -0.2% | 49.38 | USD 141,622 | |
| 2025-01-10 | 2025-01-08 | PS Planned sale |
Chief Executive Officer Executive Director |
12,132
-0.9%
48.72USD 591,071 |
12,132 -0.9% | 48.72 | USD 591,071 | |
| 2025-01-03 | 2025-01-02 | PS Planned sale |
Chief Medical Officer Officer |
100
-0.0%
47.92USD 4,792 |
100 -0.0% | 47.92 | USD 4,792 | |
| 2025-01-03 | 2025-01-02 | PS Planned sale |
Chief Medical Officer Officer |
2,486
-1.0%
47.21USD 117,364 |
2,486 -1.0% | 47.21 | USD 117,364 | |
| 2025-01-03 | 2025-01-02 | PS Planned sale |
Chief Medical Officer Officer |
1,499
-0.6%
46.42USD 69,584 |
1,499 -0.6% | 46.42 | USD 69,584 | |
| 2024-12-16 | 2024-12-12 | B Purchase | Non-Executive Director |
12,500
+166.7%
49.85USD 623,125 |
12,500 +166.7% | 49.85 | USD 623,125 | |
| 2024-12-16 | 2024-12-12 | B Purchase | Non-Executive Director |
7,500
+inf%
49.02USD 367,650 |
7,500 +inf% | 49.02 | USD 367,650 | |
| 2024-12-13 | 2024-12-11 | PS Planned sale |
Chief Medical Officer Officer |
455
-0.2%
50.00USD 22,750 |
455 -0.2% | 50.00 | USD 22,750 | |
| 2024-12-13 | 2024-12-11 | PS Planned sale |
Chief Medical Officer Officer |
4,085
-1.6%
48.62USD 198,613 |
4,085 -1.6% | 48.62 | USD 198,613 | |
| 2024-12-06 | 2024-12-04 | PS Planned sale |
Chief Executive Officer Executive Director |
1,672
-0.1%
47.19USD 78,902 |
1,672 -0.1% | 47.19 | USD 78,902 | |
| 2024-12-06 | 2024-12-04 | PS Planned sale |
Chief Executive Officer Executive Director |
13,328
-1.0%
46.50USD 619,752 |
13,328 -1.0% | 46.50 | USD 619,752 | |
| 2024-12-06 | 2024-12-04 | PS Planned sale |
Chief Medical Officer Officer |
6,665
-2.5%
46.07USD 307,057 |
6,665 -2.5% | 46.07 | USD 307,057 | |
| 2024-11-08 | 2024-11-06 | PS Planned sale |
Chief Medical Officer Officer |
1,339
-0.5%
59.96USD 80,286 |
1,339 -0.5% | 59.96 | USD 80,286 | |
| 2024-11-08 | 2024-11-06 | PS Planned sale |
Chief Medical Officer Officer |
5,326
-1.9%
58.91USD 313,755 |
5,326 -1.9% | 58.91 | USD 313,755 | |
| 2024-11-08 | 2024-11-06 | PS Planned sale |
Chief Executive Officer Executive Director |
1,000
-0.1%
59.94USD 59,940 |
1,000 -0.1% | 59.94 | USD 59,940 | |
| 2024-11-08 | 2024-11-06 | PS Planned sale |
Chief Executive Officer Executive Director |
14,000
-1.0%
59.17USD 828,380 |
14,000 -1.0% | 59.17 | USD 828,380 | |
| 2024-10-04 | 2024-10-02 | PS Planned sale |
Chief Medical Officer Officer |
925
-0.3%
56.86USD 52,596 |
925 -0.3% | 56.86 | USD 52,596 | |
| 2024-10-04 | 2024-10-02 | PS Planned sale |
Chief Medical Officer Officer |
5,740
-2.0%
56.16USD 322,358 |
5,740 -2.0% | 56.16 | USD 322,358 | |
| 2024-10-04 | 2024-10-02 | PS Planned sale |
Chief Executive Officer Executive Director |
9,712
-0.7%
56.74USD 551,059 |
9,712 -0.7% | 56.74 | USD 551,059 | |
| 2024-10-04 | 2024-10-02 | PS Planned sale |
Chief Executive Officer Executive Director |
30,288
-2.2%
56.07USD 1,698,248 |
30,288 -2.2% | 56.07 | USD 1,698,248 | |
| 2024-09-06 | 2024-09-04 | PS Planned sale |
Chief Executive Officer Executive Director |
14,359
-1.0%
48.23USD 692,535 |
14,359 -1.0% | 48.23 | USD 692,535 | |
| 2024-09-06 | 2024-09-04 | PS Planned sale |
Chief Executive Officer Executive Director |
25,641
-1.8%
47.28USD 1,212,306 |
25,641 -1.8% | 47.28 | USD 1,212,306 | |
| 2024-09-06 | 2024-09-04 | PS Planned sale |
Chief Medical Officer Officer |
787
-0.3%
48.06USD 37,823 |
787 -0.3% | 48.06 | USD 37,823 | |
| 2024-09-06 | 2024-09-04 | PS Planned sale |
Chief Medical Officer Officer |
5,878
-2.0%
47.49USD 279,146 |
5,878 -2.0% | 47.49 | USD 279,146 | |
| 2024-08-23 | 2024-08-23 | S Sale |
Chief Financial Officer Officer |
6,000
-2.9%
48.26USD 289,560 |
6,000 -2.9% | 48.26 | USD 289,560 | |
| 2024-08-09 | 2024-08-07 | PS Planned sale |
Chief Medical Officer Officer |
670
-0.2%
42.56USD 28,515 |
670 -0.2% | 42.56 | USD 28,515 | |
| 2024-08-09 | 2024-08-07 | PS Planned sale |
Chief Medical Officer Officer |
142
-0.0%
41.09USD 5,835 |
142 -0.0% | 41.09 | USD 5,835 | |
| 2024-08-09 | 2024-08-07 | PS Planned sale |
Chief Medical Officer Officer |
6,523
-2.2%
40.47USD 263,986 |
6,523 -2.2% | 40.47 | USD 263,986 | |
| 2024-08-09 | 2024-08-07 | PS Planned sale |
Chief Executive Officer Executive Director |
100
-0.0%
42.17USD 4,217 |
100 -0.0% | 42.17 | USD 4,217 | |
| 2024-08-09 | 2024-08-07 | PS Planned sale |
Chief Executive Officer Executive Director |
7,667
-0.5%
41.52USD 318,334 |
7,667 -0.5% | 41.52 | USD 318,334 | |
| 2024-08-09 | 2024-08-07 | PS Planned sale |
Chief Executive Officer Executive Director |
32,233
-2.2%
40.40USD 1,302,213 |
32,233 -2.2% | 40.40 | USD 1,302,213 | |
| 2024-07-05 | 2024-07-05 | PS Planned sale |
Chief Executive Officer Executive Director |
15,000
-1.0%
37.26USD 558,900 |
15,000 -1.0% | 37.26 | USD 558,900 | |
| 2024-07-05 | 2024-07-03 | PS Planned sale |
Chief Medical Officer Officer |
2,143
-0.7%
38.16USD 81,777 |
2,143 -0.7% | 38.16 | USD 81,777 | |
| 2024-07-05 | 2024-07-03 | PS Planned sale |
Chief Medical Officer Officer |
3,852
-1.3%
37.29USD 143,641 |
3,852 -1.3% | 37.29 | USD 143,641 | |
| 2023-07-17 | 2023-07-13 | B Purchase |
Fairmount Funds Management LLC Non-Executive Director |
892,529
+inf%
17.00USD 15,172,993 |
892,529 +inf% | 17.00 | USD 15,172,993 | |
| 2023-07-17 | 2023-07-13 | B Purchase |
Fairmount Funds Management LLC Non-Executive Director |
1,992,734
+inf%
17.00USD 33,876,478 |
1,992,734 +inf% | 17.00 | USD 33,876,478 | |
| 2023-07-17 | 2023-07-13 | B Purchase |
Fairmount Funds Management LLC Non-Executive Director |
55,913
+inf%
17.00USD 950,521 |
55,913 +inf% | 17.00 | USD 950,521 | |
| 2023-07-17 | 2023-07-13 | B Purchase | Non-Executive Director |
1,750,000
+inf%
17.00USD 29,750,000 |
1,750,000 +inf% | 17.00 | USD 29,750,000 |